Starting systemic steroids for irAEs more than 2 months after immune checkpoint inhibitor initiation was associated with longer survival. Treating immune-related adverse events (irAEs) with systemic ...
A reduced-dose steroid regimen in high-risk IgaN may offer the best balance of risks vs benefits, an investigator stated. In patients with high-risk IgA nephropathy (IgAN), a 6 month to 9 month course ...
Dupilumab for bullous pemphigoid induced by immune checkpoint inhibitors. Real-life use of G-CSF in patients with small cell lung cancer (SCLC): Secondary data analysis from the French national ...
Last week the Food and Drug Administration alerted healthcare providers of seven adverse events associated with steroid injections compounded at Main Street Family Pharmacy in Newbern, Tenn. Further ...
Please provide your email address to receive an email when new articles are posted on . A 6-week corticosteroids regimen significantly improved treatment success for immune-related pneumonitis ...
With new guidelines for the treatment of moderate to severe asthma, experts noted a shift toward increasing caution in corticosteroid use. "I think the shift from the guidelines and from all the data ...
Patients with atopic dermatitis reported that exposure to corticosteroid treatment throughout their lifetime put them at a risk for negative outcomes. A study published in Annals of Allergy, Asthma, & ...
In 2019, approximately 40% of oncology patients in the United States were eligible for treatment with immune checkpoint inhibitors (ICIs). Furthermore, it is estimated that one in seven patients who ...
A reduced-dose steroid regimen in high-risk IgaN may offer the best balance of risks vs benefits, an investigator stated. The following article features coverage from the American Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results